Pfizer's Xalkori holds off pre-treated cancer in study; Lilly re-launches share buybacks;

 @FiercePharma: Merck Serono's final answer: We'll close the Geneva HQ as planned. Protesting workers did win a few concessions. More | Follow @FiercePharma

> Pfizer ($PFE) released study results showing its targeted lung cancer drug, Xalkori, boosted progression-free survival in previously treated patients with advanced ALK-positive disease. Report

> Eli Lilly ($LLY) is joining the share-buyback club by resuming a long-ago-authorized $2.58 billion plan; it expects to wrap up the remaining $420 million by year's end. News

> In more consolidation for the pharmacy business, Walgreen agreed to buy 45% of U.K.'s Alliance Boots for $6.7 billion, with an option to acquire the rest. Story

> GlaxoSmithKline ($GSK) and Novartis ($NVS) won U.S. government contracts to develop and manufacture medicines and vaccines to fight pandemics and bioterror threats. Item

> Patient groups are lamenting the U.K. cost effectiveness watchdog's draft decision to deny reimbursement for Roche's ($RHHBY) new targeted melanoma drug Zelboraf. Article

Biotech News

 @FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

 @JohnCFierce: Thanks to Bernard Munos, Jim Burns, Jason Gardner, Jill Milne, Mene Pangalos and 300+ of my closest friends for a great conversation this a.m. | Follow @JohnCFierce

 @RyanMFierce: Danish biotech Nuevolution snagged €11 Million in new financing round. Release | Follow @RyanMFierce

> Millennium wants to rival top 10 drugmakers in oncology. Story

> E&Y: Biotech looks stable, but warning signs cloud the future. Article

> Novartis, Emergent headline $400M HHS plan to combat health threats. News

> Roche, Seaside join forces against autism and Fragile X. More

> Biotech beats overall economy in jobs report. Item

Medical Devices News

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Our coverage of the 2012 BIO International Convention continues. Roundup | Follow @MarkHFierce

> Medical device/Dx VC funding has gotten 'a little' better. Report

> China Medical's investors petition for liquidation. News

> At BIO, experts rethink how to make companion diagnostics viable. Article

> A declining rupee could spell trouble for India's medical equipment imports. Item

Pharma Manufacturing News

> Amneal Pharmaceuticals quadruples manufacturing. Item

> Just about everyone agrees: drug shortages are a complex puzzle. Story

> Canadian Internet pharmacy leader faces federal charges. Article

Biotech Research News

> In life sciences R&D, China is reaching for the stars. Editor's corner

> Pluristem's placental stem cells spur bone marrow growth. Story

> Genetic markers uncovered for rare children's brain tumor. Report

> Breakthrough: Human Microbiome Project maps healthy body microbes. More

And Finally... Exposure to antibacterial chemicals and preservatives in soap, toothpaste and the like may promote allergies in children. News

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.